Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Huntington Disease
 More »

  • Why Junk Is Good for the Brain
    noncoding RNAs and Huntington's disease. He also found weaker associations between specific groups of long noncoding RNAs and Alzheimer's disease, convulsive seizures, major ...
    4-16-2013
  • Roche and Isis Pharmaceuticals Set Sights on Huntington's
    for Huntington's disease (HD) based on Isis' antisense oligonucleotide (ASO) technology. ... Huntington's disease is an inherited genetic brain disorder that results in the ...
    4-8-2013
  • Potential Prion Disease Therapy Uncovered
    in treating fatal disorders, such as Creutzfeldt-Jakob disease (the human equivalent of mad cow disease), says the team at the Florida campus of The Scripps Research Institute. ...
    4-4-2013
  • Stem Cell Lines
    NSW 2000 Genea Stem Cells (GSC) develops disease-specific pluripotent and differentiated ... GSC supplies application-ready, disease-affected and control differentiated cell ...
    3-15-2013
  • Zapping Pathological Proteins in Alzheimer's
    AC Immune Takes Aim at Misfolded Abeta and Tau, as Firm Eyes Disease Prevention AC ... AC Immune is fighting Alzheimer's disease on three fronts armed with monoclonal ...
    3-1-2013
  • New Method Enables Multiplex Genome Engineering
    to study human disease, and to develop new therapies, among other potential applications. ... new therapies for diseases such as Huntington's disease, caused by a single abnormal gene. ...
    1-3-2013
  • Evotec Acquires Cell Supplier
    in recent months with Bayer (endometriosis) and CHDI Foundation (Huntington's disease); "significant" milestone revenue from Andromeda/Teva, Boehringer Ingelheim, and ...
    1-3-2013
  • The New Economics of Orphan Diseases
    Opportunities Abound in Rare Disease Space as Market Is Projected to Continue Growing Top ... waivers attract multinational corporations to the rare disease segment," Munjal explains. ...
    1-1-2013
  • Nuron, Raptor in Royalty Deals
    marketed for prevention of invasive disease caused by Neisseria meningitidis ... RP103 is also in clinical development for the potential treatment of Huntington's disease ...
    12-20-2012
  • Genmab Reaches Third Rung in Lundbeck Collab
    to aid preclinical development of Lundbeck's Huntington's disease therapeutic candidate, particularly focusing on the compound's effects on P2X receptors implicated in the disease. ...
    12-13-2012
  • uniQure and Benitec Enter Cross-Licensing Agreement
    to Benitec's DNA-directed RNA interference (ddRNAi) technology in Huntington's disease. ... that lies at the basis of Huntington's disease, and to develop a therapy for this ...
    12-5-2012
  • Screen Reveals Hundreds of Potential HD Targets
    to toxicity associated with Huntington's disease (HD), hoping that some of them may lead ... genes that seem to be modifying the Huntington toxicity phenotype, where we can start ...
    11-30-2012
  • Horizon Applies Gene Editing to Huntington's Disease
    The partnership will focus on the creation of human isogenic disease model cell lines with insertion of Huntington's disease-causing triplet repeats. The company will provide UCL ...
    11-8-2012
  • In Vitro Clinical Trials: Not that Far-Fetched
    researchers to screen for drugs to treat cardiovascular disease and other conditions. ... from normal individuals to clinical and disease cohorts, and individuals who experience ...
    10-31-2012
  • Evotec, CHDI Extend Huntington's Disease Collaboration
    Evotec could receive up to $41 million in research fees from the Huntington's disease ... novel drugs against Huntington's disease, continues to work in partnership with ...
    10-29-2012
  • More »

    Journal Articles

  • Purmorphamine Increases DARPP-32 Differentiation in Human Striatal...
    Gehan El-Akabawy, Lourdes Martinez Medina, Aaron Jeffries, Jack Price, Michel Modo
    Stem Cells and Development
    Transplantation of neural stem cells (NSCs) is a promising therapeutic approach for Huntington's disease (HD). HD is characterized by a progressive loss of medium-sized spiny ...
  • Peer-Professional Workgroups in Palliative Care: A Strategy for...
    Ira Byock, Jeanne Sheils Twohig, Melanie Merriman, Karyn Collins
    Journal of Palliative Medicine
    disease-based, specialty-based or issue-based workgroups (the selected workgroup topics were amyotrophic lateral sclerosis, cost accounting, critical care, end-stage renal disease, ...
  • Possible Neuroprotective Effect of Withania somnifera Root Extract...
    Puneet Kumar, Anil Kumar
    Journal of Medicinal Food
    Dysfunction in an Animal Model of Huntington's Disease Journal of Medicinal Food Abstract Huntington's disease (HD) is a neurodegenerative disorder that results from the ...
  • Adenovirus-Mediated Silencing of Huntingtin Expression by shRNA
    Bin Huang, Stefan Kochanek
    Human Gene Therapy and Part B: Methods
    Human Gene Therapy and Part B: Methods Huntington's disease (HD) is an inherited autosomal dominant, neurodegenerative disease that is caused by a gain of function mutation ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll